rakuten-med.com

Website review rakuten-med.com

Rakuten Medical - To conquer cancer.

 Generated on May 01 2026 23:47 PM

Old data? UPDATE !

The score is 50/100

SEO Content

Title

Rakuten Medical - To conquer cancer.

Length : 36

Perfect, your title contains between 10 and 70 characters.

Description

Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox™ technology platform which, in pre-clinical studies have been shown to induce rapid and selective cell killing and tumor necrosis.Rakuten Medical is committed to its mission to conquer cancer and aims to realize a society where cancer patients can lead fulfilling lives.

Length : 406

Ideally, your meta description should contain between 70 and 160 characters (spaces included). Use this free tool to calculate text length.

Keywords

Very bad. We haven't found meta keywords on your page. Use this free online meta tags generator to create keywords.

Og Meta Properties

Good, your page take advantage of Og Properties.

Property Content
locale en-US
type website
title Rakuten Medical - To conquer cancer.
description Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Alluminox™ technology platform which, in pre-clinical studies have been shown to induce rapid and selective cell killing and tumor necrosis.Rakuten Medical is committed to its mission to conquer cancer and aims to realize a society where cancer patients can lead fulfilling lives.
url https://rakuten-med.com/us/
site_name Rakuten Medical - To conquer cancer.
image https://rakuten-med.com/us/wp-content/uploads/sites/6/2019/05/mainvisual_01_en.jpg
image:width 1500
image:height 900
image:type image/png
image:url https://rakuten-med.com/us/wp-content/uploads/sites/6/2019/05/mainvisual_01_en.jpg
image:secure_url https://rakuten-med.com/us/wp-content/uploads/sites/6/2019/05/mainvisual_01_en.jpg

Headings

H1 H2 H3 H4 H5 H6
0 5 26 1 0 0
  • [H2] Press Release
  • [H2] Rakuten Medical Stories
  • [H2] Letter from Our CEO
  • [H2] Letter fromOur CEO
  • [H2] Our Mission
  • [H3] Rakuten Medical Announces Two Poster Presentations and Exhibit Booth at ASCO 2026 Annual Meeting
  • [H3] Rakuten Medical Presents New Preclinical Findings at AACR 2026 Showing COX‑2 Inhibition Reduces Photoimmunotherapy‑Induced Edema via PGE₂ Suppression
  • [H3] Rakuten Medical’s 2nd R&D Day featured the preliminary safety and efficacy data for Alluminox treatment using ASP-1929 in combination with anti-PD-1 therapy
  • [H3] Rakuten Medical R&D Day shared comprehensive overview of investigational Alluminox™ platform and the promising scientific and clinical data for ASP-1929/RM-1929 based on the platform
  • [H3] Rakuten Medical Announces Two Poster Presentations and Exhibit Booth at ASCO 2026 Annual Meeting
  • [H3] Rakuten Medical Presents New Preclinical Findings at AACR 2026 Showing COX‑2 Inhibition Reduces Photoimmunotherapy‑Induced Edema via PGE₂ Suppression
  • [H3] Rakuten Medical Announces First Patient Treated in Ukraine in Global Phase 3 Trial of ASP-1929 Photoimmunotherapy + Pembrolizumab for 1L Recurrent Head and Neck Cancer
  • [H3] Rakuten Medical’s 2nd R&D Day featured the preliminary safety and efficacy data for Alluminox treatment using ASP-1929 in combination with anti-PD-1 therapy
  • [H3] Rakuten Medical R&D Day shared comprehensive overview of investigational Alluminox™ platform and the promising scientific and clinical data for ASP-1929/RM-1929 based on the platform
  • [H3] Rakuten Medical aims to transform head and neck cancer treatments in India
  • [H3] Help came too late for my father
  • [H3] Help came too late for my father
  • [H3] Mission
  • [H3] Vision
  • [H3] Focus
  • [H3] About Us
  • [H3] Alluminox®
  • [H3] Alluminox®
  • [H3] Pipeline
  • [H3] Partnering
  • [H3] Partnering
  • [H3] News
  • [H3] Careers
  • [H3] Contact
  • [H3] Careers
  • [H3] Contact
  • [H4] Privacy Overview

Images

We found 20 images on this web page.

18 alt attributes are empty or missing. Add alternative text so that search engines can better understand the content of your images.

Text/HTML Ratio

Ratio : 1%

This page's ratio of text to HTML code is below 15 percent, this means that your website probably needs more text content.

Flash

Perfect, no Flash content has been detected on this page.

Iframe

Great, there are no Iframes detected on this page.

URL Rewrite

Good. Your links looks friendly!

Underscores in the URLs

Perfect! No underscores detected in your URLs.

In-page links

We found a total of 33 links including 0 link(s) to files

Anchor Type Juice
Rakuten Medical - To conquer cancer. Internal Passing Juice
About Us Internal Passing Juice
Letter from Our CEO Internal Passing Juice
Leadership Internal Passing Juice
Location Internal Passing Juice
Alluminox® Internal Passing Juice
Pipeline Internal Passing Juice
Expanded Access Program Internal Passing Juice
Press Releases Internal Passing Juice
Rakuten Medical Stories Internal Passing Juice
Events & Presentations Internal Passing Juice
Press Kit Internal Passing Juice
Careers Internal Passing Juice
Contact Us Internal Passing Juice
Global Internal Passing Juice
Japan Internal Passing Juice
Taiwan Internal Passing Juice
Rakuten Medical Announces Two Poster Presentations and Exhibit Booth at ASCO 2026 Annual Meeting Internal Passing Juice
Rakuten Medical Presents New Preclinical Findings at AACR 2026 Showing COX‑2 Inhibition Reduces Photoimmunotherapy‑Induced Edema via PGE₂ Suppression Internal Passing Juice
Rakuten Medical’s 2nd R&D Day featured the preliminary safety and efficacy data for Alluminox treatment using ASP-1929 in combination with anti-PD-1 therapy Internal Passing Juice
Rakuten Medical R&D Day shared comprehensive overview of investigational Alluminox™ platform and the promising scientific and clinical data for ASP-1929/RM-1929 based on the platform Internal Passing Juice
Rakuten Medical Announces First Patient Treated in Ukraine in Global Phase 3 Trial of ASP-1929 Photoimmunotherapy + Pembrolizumab for 1L Recurrent Head and Neck Cancer Internal Passing Juice
Rakuten Medical aims to transform head and neck cancer treatments in India Internal Passing Juice
Letter from Our CEO Internal Passing Juice
Leadership Internal Passing Juice
Pipeline Internal Passing Juice
Expanded Access Program Internal Passing Juice
Partnering Internal Passing Juice
News Internal Passing Juice
News Internal Passing Juice
Press Releases Internal Passing Juice
Contact Internal Passing Juice
Privacy Policy Internal Passing Juice

SEO Keywords

Keywords Cloud

website cookie policy personal necessary cookies enhance enabled privacy information

Keywords Consistency

Keyword Content Title Keywords Description Headings
cookies 7
website 6
privacy 4
necessary 3
information 3

Usability

Url

Domain : rakuten-med.com

Length : 15

Favicon

Great, your website has a favicon.

Printability

Great. We have found a Print-Friendly CSS.

Language

Good. Your declared language is en.

Dublin Core

This page does not take advantage of Dublin Core.

Document

Doctype

HTML 5

Encoding

Perfect. Your declared charset is UTF-8.

W3C Validity

Errors : 0

Warnings : 0

Email Privacy

Great no email address has been found in plain text!

Deprecated HTML

Great! We haven't found deprecated HTML tags in your HTML.

Speed Tips

Excellent, your website doesn't use nested tables.
Too bad, your website is using inline styles.
Too bad, your website has too many CSS files (more than 4).
Too bad, your website has too many JS files (more than 6).
Too bad, your website does not take advantage of gzip.

Mobile

Mobile Optimization

Apple Icon
Meta Viewport Tag
Flash content

Optimization

XML Sitemap

Great, your website has an XML sitemap.

https://rakuten-med.com/us/sitemap_index.xml

Robots.txt

https://rakuten-med.com/robots.txt

Great, your website has a robots.txt file.

Analytics

Great, your website has an analytics tool.

   Google Analytics

PageSpeed Insights


Device
Categories

Free SEO Testing Tool

Free SEO Testing Tool is a free SEO tool which provides you content analysis of the website.